Dawod PGA, Jancic J, Marjanovic A, Brankovic M, Jankovic M, Samardzic J, Gamil Anwar Dawod A, Novakovic I, Abdel Motaleb FI, Radlovi V, Kostic VS, Nikolic D. Mutational Analysis and mtDNA Haplogroup Characterization in Three Serbian Cases of Mitochondrial Encephalomyopathies and Literature Review. Diagnostics 2021;11:1969.
Rovcanin B, Jancic J, Pajic J, Rovcanin M, Samardzic J, Djuric V, Nikolic B, Ivancevic N, Novakovic I, Kostic V. Oxidative Stress Profile in Genetically Confirmed Cases of Leber's Hereditary Optic Neuropathy. J Mol Neurosci. 2021;71(5):1070-1081.
Bespalov A, Bernard R, Gilis A, et al. (Samardzic J). Introduction to the EQIPD quality system. Elife 2021;10:e63294
Nikolić B, Ivančević N, Zaletel I, Rovčanin B, Samardžić J, Jančić J. Characteristics of pediatric multiple sclerosis: A tertiary referral center study. PLoS One 2020; 15(12):e0243031.
Jancic J, Djuric V, Hencic B, van den Anker JN, Samardzic J. Comorbidity of Migraine and Epilepsy in Pediatrics: A Review. J Child Neurol. 2018; 33(12):801-808.
Samardzic J, Hencic B, Jancic J, Jadzic D, Djuric M, Obradovic DI, Svob Strac D. Neurosteroid dehydroepiandrosterone improves active avoidance retrieval and induces antidepressant-like behavior in rats. Neurosci Lett. 2017;660:17-21.
Jancic J, Duric V, Ivancevic N, Nikolic B, van den Anker JN, Samardzic J. Current use of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas and epilepsy in patients with TSC. Curr Med Chem. 2016; 23(37): 4260-9.
Samardzic J, Allegaert K, Wilbaux M, Pfister M, van den Anker JN. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period. Expert Opin Drug Metab Toxicol. 2016; 12(4):367-75.
Samardzic J, Allegaert K, Bajcetic M. Developmental pharmacology: a moving target. Int J Pharm. 2015; 492(1-2): 335-7.
Ferrario A, Baltezarevic D, Novakovic T, Parker M, Samardzic J. Evidence-based decision making in healthcare in Central Eastern Europe. Expert Rev Pharmacoecon Outcomes Res 2014;14(5):611-615.